Home ⟩ Insights

Insights

biotech

2 min read • February 27, 2023

SciSparc Signs Agreement For The Supply Of CBD-Rich Cannabis Oil For Its Clinical Trial On Children With Autism Spectrum Disorder

3 min read • February 24, 2023

Take Care Of Your Heart: Risk Of Coronary Artery Disease Among Regular Cannabis Users, Study Finds

2 min read • February 21, 2023

High Blood Pressure? Cannabis Use May Be A Surprising Solution, A New Study Finds

2 min read • February 21, 2023

Lexaria Discovers Potential Novel Mechanism From Hypertension Study Of Processed CBD

2 min read • February 17, 2023

Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says

2 min read • February 15, 2023

Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment

4 min read • February 13, 2023

‘Hawaii Senators Approve Bill To Promote Research Into Psilocybin And MDMA Therapy’ – Marijuana Moment

1 min read • January 13, 2023

‘New York Governor Signs Bill To Mandate State Legalization Of Schedule I Drugs Like Psilocybin And MDMA If Federal Law Changes’ – Marijuana Moment

2 min read • December 21, 2022

Reported Late Tuesday, New York Selects Forian’s Biotrack As The State’s Cannabis Seed To Sale Track And Trace System

4 min read • December 9, 2022

‘Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts’ – MarijuanaMoment

2 min read • December 2, 2022

Cannabis For Tourette Syndrome? Significant Improvement In Quality Of Life, Finds Israeli Study

2 min read • December 1, 2022

An Eye Scanner That Detects Cannabis Use? It Exists And The Police Could Implement It Soon

Latest Headlines

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.